Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Klara Owen"'
Autor:
Iben Rix, Lars F. Garvey, Jens J. Holst, Tina Vilsbøll, Filip K. Knop, Asger Lund, Gerrit van Hall, Carsten P. Hansen, Klara Owen
Publikováno v:
Diabetes. 70
Glucagon secretion and signaling are affected in several metabolic disorders including different types of diabetes. To understand these mechanisms better, we investigated the effect of exogeneous glucagon in participants deprived of endogenous glucag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8354d7a574dd6c9133583275e1cb4e0f
https://doi.org/10.2337/db21-1191-p
https://doi.org/10.2337/db21-1191-p
Autor:
Louis Vignati, Matthias H. Tschöp, Rune Haubo Bojesen Christensen, Richard D. DiMarchi, Edward J. Bastyr, Klara Owen, Christophe Schmitt, Juan Pablo Frias
Publikováno v:
Cell Metab. 26, 343-352.e2 (2017)
Unimolecular dual incretins derived from hybridized glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) sequences have demonstrated synergistic reduction of adiposity in animal models and reductions of hyperglycemia in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae952d6ab742c0fe47c346f63da14707
https://pubmed.ncbi.nlm.nih.gov/28768173
https://pubmed.ncbi.nlm.nih.gov/28768173
Publikováno v:
IFAC Proceedings Volumes. 36:95-97
Metabolic (Reaven's) syndrome is a set of metabolic abnonnalities including common diseases e.g. diabetes, hypertension. According to unknown pathogenesis quantitative approaches are used to analyse the adherence of the syndrome components. We have d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00602671a14add5b3ecf7d5b0da2ae71
https://doi.org/10.1016/s1474-6670(17)33480-8
https://doi.org/10.1016/s1474-6670(17)33480-8
Autor:
Klara Owen, Jindra Perusicova
Publikováno v:
Topics in the Prevention, Treatment and Complications of Type 2 Diabetes
The pharmacotherapy of Type 2 Diabetes Mellitus (T2DM) has, in the past 60 years, been developing in unison with the advances in our understanding of diabetes pathophysiology. As our knowledge developed and changed, so did appear new drugs which bett
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69a381474606c81cbebb361c71edfa42
https://doi.org/10.5772/21873
https://doi.org/10.5772/21873
